- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISBN
-
9783848709915
3848709910
- Dimensions
-
23 cm
- Extent
-
84 S.
- Edition
-
1. Aufl.
- Language
-
Englisch
- Notes
-
graph. Darst.
Zugl.: München, Munich Intellectuel Property Law Center, Masterarbeit, 2012
- Bibliographic citation
-
MIPLC studies / Munich Intellectual Property Law Center ; Vol. 20
- Classification
-
Recht
- Event
-
Veröffentlichung
- (where)
-
Baden-Baden
- (who)
-
Nomos
- (when)
-
2014
- Creator
-
Donghi, Monica
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.06.2025, 2:18 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Donghi, Monica
- Nomos
Time of origin
- 2014
Other Objects (12)
Evaluating the US pharmaceutical patent policy
Second generation patents in pharmaceutical innovation
The right to health in pharmaceutical patent disputes
Pharmaceutical patents: incentives for R&D or marketing?
Optimal incentives for patent challenges in the pharmaceutical industry
Optimal Incentives for Patent Challenges in the Pharmaceutical Industry
Optimal Incentives for Patent Challenges in the Pharmaceutical Industry
Optimal Incentives for Patent Challenges in the Pharmaceutical Industry
TRIPS flexibilities on patent enforcement: Lessons from some developed countries relating to pharmaceutical patent protection
Law and Economics of Patent Settlements in the Pharmaceutical Industry
Implementing pro-competitive criteria for the examination of pharmaceutical patents
Law and economics of patent settlements in the pharmaceutical industry
Evaluating the US pharmaceutical patent policy
Second generation patents in pharmaceutical innovation
The right to health in pharmaceutical patent disputes
Pharmaceutical patents: incentives for R&D or marketing?
Optimal incentives for patent challenges in the pharmaceutical industry
Optimal Incentives for Patent Challenges in the Pharmaceutical Industry
Optimal Incentives for Patent Challenges in the Pharmaceutical Industry
Optimal Incentives for Patent Challenges in the Pharmaceutical Industry
TRIPS flexibilities on patent enforcement: Lessons from some developed countries relating to pharmaceutical patent protection
Law and Economics of Patent Settlements in the Pharmaceutical Industry
Implementing pro-competitive criteria for the examination of pharmaceutical patents
Law and economics of patent settlements in the pharmaceutical industry
Evaluating the US pharmaceutical patent policy
Second generation patents in pharmaceutical innovation
The right to health in pharmaceutical patent disputes
Pharmaceutical patents: incentives for R&D or marketing?
Optimal incentives for patent challenges in the pharmaceutical industry
Optimal Incentives for Patent Challenges in the Pharmaceutical Industry
Optimal Incentives for Patent Challenges in the Pharmaceutical Industry
Optimal Incentives for Patent Challenges in the Pharmaceutical Industry
TRIPS flexibilities on patent enforcement: Lessons from some developed countries relating to pharmaceutical patent protection
Law and Economics of Patent Settlements in the Pharmaceutical Industry
Implementing pro-competitive criteria for the examination of pharmaceutical patents